55.8% PTCL-NOS, 57.1% NKTCL, 86.7% ALCL, and 50% AITL strongly expressed HDAC1; 58.1% PTCL-NOS, 57.1% NKTCL, 53.3% ALCL, and 60% AITL strongly expressed HDAC2 (64). The gene discussed is HDAC1; the disease is extranodal nasal NK/T cell lymphoma.